Alaunos Therapeutics | ZIOP - Current Liabilities


Alaunos Therapeutics reported $595K in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Alaunos Therapeutics USD 595K 218K Mar/2026
Amgen USD 24.96B 534M Mar/2026
AstraZeneca USD 32.57B 1.95B Mar/2026
Baxter International USD 3.69B 723M Mar/2026
Biogen USD 3B 350.5M Mar/2026
Bioline Rx USD 13.67M 1.81M Sep/2025
Bristol-Myers Squibb USD 19.16B 4.26B Mar/2026
Celltrion KRW 283.62B 3.72T Dec/2025
Corcept Therapeutics USD 149.18M 16.9M Mar/2026
Cspc Pharmaceutical CNY 10.18B 65.36M Dec/2025
Curis USD 14.08M 5.3M Dec/2025
Deva Holding AS TRY 6.43B 1.18B Sep/2023
Dianthus Therapeutics USD 38.28M 7.55M Mar/2026
Divis Laboratories Ltd INR 20.43B 3.15B Mar/2026
Gilead Sciences USD 9.48B 2.34B Mar/2026
GlaxoSmithKline GBP 22.43B 1.04B Mar/2026
Incyte USD 1.49B 25.52M Mar/2026
Intrexon USD 23.02M 38K Jun/2024
Ionis Pharmaceuticals USD 717M 66M Mar/2026
J&J USD 57.72B 3.59B Mar/2026
Kangmei Pharma CNY 5.38B 433.79M Mar/2026
Karyopharm Therapeutics USD 92.06M 4.9M Dec/2025
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Laboratorios Farma EUR 199.84M 121.75M Dec/2023
Malin Corporation EUR 1000K 500K Dec/2024
Medical Developments International AUD 5.56M 2.26M Dec/2025
Merck USD 26.94B 1.38B Mar/2026
Neuren Pharmaceuticals AUD 4.34M 3.58M Dec/2025
Novartis USD 31.37B 4.1B Mar/2026
Organigram Holdings CAD 94.05M 32.11M Dec/2025
Ovoca Bio EUR 186K 2.26M Jun/2025
Pfizer USD 34.35B 2.64B Mar/2026
Pharma Mar EUR 89.23M 4.65M Mar/2026
PTC Therapeutics USD 923.6M 44.82M Mar/2026
Qiagen NV USD 512.14M 461.26M Dec/2025
Regeneron Pharmaceuticals USD 5.11B 739.3M Mar/2026
Roche Holding CHF 28B 421M Dec/2025
Sangamo BioSciences USD 47.66M 1.9M Jun/2025
Sartorius EUR 2.11B 145.8M Mar/2026
Sino Biopharmaceutical CNY 24.85B 5.29B Jun/2025
TG Therapeutics USD 187.11M 33.35M Mar/2026
Tilray USD 259.32M 8.32M Sep/2025
Verastem USD 72.27M 12.56M Dec/2025
Zealand Pharma A/S 664.96M 513.61M Dec/2025
Zz Pientze Pharmaceu CNY 2.28B 134.52M Mar/2026